Key stocks that moved the most on November 3 | Tech US News

[ad_1]

SBI, HPCL, Tech Mahindra and more: Key stocks that moved the most on November 3
Time to read

Read for 2 minutes

Profile image

by the CNBCTV18.com IST (Published)

to change Slide show

Abstract

Indian benchmark indices ended Thursday’s trading session marginally lower. The NSE Nifty 50 ended down 30.15 points at 18052.70 and the BSE Sensex was down 69.68 points at 60836.41. These are the main stocks that moved the most.

hpcl, hpcl stock, hpcl shares, important stocks, stocks that moved, stock market india,
1 / 6

Hindustan Petroleum Corporation Limited Hindustan Petroleum Corporation Limited’s net loss in the September quarter narrowed due to one-time LPG grant provided by the government. Excluding Grant, the results are marginally better than estimates. The stock ended down 1.7 percent.

2 / 6

Tech Mahindra | The Nifty 50 was the top loser, with the stock closing down 2.6 percent.

Bank of Baroda, Canara Bank, SBI, PSB, Indian Bank, Indian Overseas Bank, Union Bank, Bank of Maharashtra, Bank of India, Punjab National Bank, UCO Bank, Central Bank of India, Bankstock, bank shares, nifty psu bank nifty 50 sectoral index,
3 / 6

Bank Stock | The Nifty PSU Bank Index was the highest gainer among the sectoral indices. Shares of Bank of Baroda, Canara Bank, SBI, PSB, Indian Bank, Indian Overseas Bank, Union Bank, Bank of Maharashtra, Bank of India, Punjab National Bank, UCO Bank, Central Bank of India from 1 to 6.6 percent. increased to

4 / 6

Mahindra & Mahindra Financial Services Ltd The Nifty500’s top gainer, its stock ended up nearly 13.6 percent.

5 / 6

HDFC Limited | Housing Development Finance Corporation (HDFC) — India’s largest mortgage lender — on Thursday reported a net profit of Rs 4,454 crore for the July-September period, beating Street estimates. Its quarterly net profit, after taking into account tax expenses of Rs 960 crore, saw a growth of 17.8 percent over the same period a year ago, driven by strong demand for home loans. The stock closed down 0.4 percent.

6 / 6

Alembic Pharmaceuticals Ltd | The company received final approval from the US drug regulator for Ketorolac Tromethamine Injection. The stock closed up 7.6 percent.

[ad_2]

Source link

Please disable your adblocker or whitelist this site!